Vertex Pharmaceuticals (VRTX)

Net Change in Cash

$1.17B

TTM · Period ending: · USD

VRTX logo

VRTX Net Change in Cash

Latest reported$1.17B
VRTX TTM Net Change in Cash (-$1.20M → $1.17B)
High-resolution chart · PNG

VRTX net change in cash history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Net Change in Cash — Trailing twelve months (TTM) (USD)
Period endingNet Change in Cash (USD)
1,172,100,000
819,500,000
515,600,000
-300,300,000
391,000,000
-4,484,000,000
-5,800,100,000
-5,868,500,000
-5,562,400,000
-126,200,000
-139,700,000
1,939,600,000
1,449,300,000
1,691,600,000
3,711,900,000
2,896,787,000
2,633,032,000
1,291,093,000
811,255,000
919,228,000
1,235,368,000
2,710,943,000
2,868,164,000
1,956,394,000
1,534,054,000
700,432,000
462,428,000
917,540,000
1,147,578,000
895,804,000
990,727,000
1,099,971,000
928,824,000
999,935,000
481,467,000
665,274,000
617,264,000
399,434,000
469,177,000
-36,558,000
-264,677,000
-60,634,000
89,509,000
37,687,000
449,985,000
240,834,000
55,960,000
135,382,000
-110,689,000
44,946,000
79,892,000
146,295,000
77,186,000
111,176,000
14,087,000
-105,659,000
-4,134,000
-178,613,000
232,123,000
-27,356,000
120,587,000
49,989,000
-203,461,000
10,768,000
-71,341,000
-205,652,000
57,543,000
16,257,000
-140,683,000
111,503,000
33,452,000
288,897,000
380,914,000
136,368,000
142,492,000
-229,452,000
127,288,000
272,501,000
135,126,000
381,812,000
-153,265,000
44,456,000
23,039,000
64,582,000
131,003,000
-15,636,000
-43,153,000
-40,412,000
-69,718,000
-127,766,000
-9,939,000
-26,145,000
8,142,000
4,544,000
-81,107,000
-92,357,000
-43,259,000
-46,433,000
-132,885,000
-275,478,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.